Lung transplantation for acute COVID-19: the Toronto Lung Transplant Program experience
Open Access
- 26 September 2021
- journal article
- editorial
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 193 (38), E1494-E1497
- https://doi.org/10.1503/cmaj.211143
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countriesThe Lancet Respiratory Medicine, 2021
- SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysisThe Lancet Microbe, 2020
- Intensive Care Unit-Acquired Weakness: Not Just Another Muscle Atrophying ConditionInternational Journal of Molecular Sciences, 2020
- Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registryThe Lancet, 2020
- Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patientThe Lancet. Respiratory Medicine, 2020
- When to consider lung transplantation for COVID-19The Lancet Respiratory Medicine, 2020
- Pulmonary fibrosis secondary to COVID-19: a call to arms?The Lancet Respiratory Medicine, 2020
- Lung Transplantation for Elderly Patients With End-Stage COVID-19 PneumoniaAnnals of Surgery, 2020
- The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart–Lung Transplant Report—2016; Focus Theme: Primary Diagnostic Indications for TransplantThe Journal of Heart and Lung Transplantation, 2016
- Effect of changes in postoperative spirometry on survival after lung transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2012